Zobrazeno 1 - 10
of 1 617
pro vyhledávání: '"MUC1, mucin 1"'
Publikováno v:
Advanced Drug Delivery Reviews
Graphical abstract
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76811ce2af0ea0f7b3342230007c3c01
https://doi.org/10.1016/j.addr.2021.03.018
https://doi.org/10.1016/j.addr.2021.03.018
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wang, Peike, Du, Shuailin, Guo, Chuanhui, Ni, Zhangli, Huang, Ziying, Deng, Na, Bao, Haili, Deng, Wenbo, Lu, Jinhua, Kong, Shuangbo, Zhang, Hua, Wang, Haibin
Publikováno v:
Autophagy; Jan2024, Vol. 20 Issue 1, p58-75, 18p
Autor:
Sang W. Hyun, Hideharu Ishida, Akihiro Imamura, Simeon E. Goldblum, Erik P. Lillehoj, Kurt H. Piepenbrink
Publikováno v:
The Journal of Biological Chemistry
The extracellular domain (ED) of the membrane-spanning sialoglycoprotein, mucin-1 (MUC1), is an in vivo substrate for the lysosomal sialidase, neuraminidase-1 (NEU1). Engagement of the MUC1-ED by its cognate ligand, Pseudomonas aeruginosa-expressed f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc5cb166a1864c8274f33d17bbe381c
https://doi.org/10.1016/j.jbc.2021.101337
https://doi.org/10.1016/j.jbc.2021.101337
Autor:
Li, Xiukuan1,2 (AUTHOR), Bai, Fenghua3 (AUTHOR), Wei, Xingwei1 (AUTHOR), Jin, Tianbo4,5 (AUTHOR), Li, Chen6 (AUTHOR), Zhang, Yutian1 (AUTHOR), Lin, Mei1 (AUTHOR), Zhou, Xiaoli1 (AUTHOR), Xie, Yufei1 (AUTHOR), He, Chanyi1 (AUTHOR), Lin, Qi1 (AUTHOR), He, Ping1 (AUTHOR) heping2882@126.com, Chu, Shuyuan7 (AUTHOR) emilyyuanchu@163.com, Ding, Yipeng1 (AUTHOR) dingyipengnov27@163.com
Publikováno v:
BMC Cancer. 2/10/2022, Vol. 22 Issue 1, p1-9. 9p.
Publikováno v:
Pancreas
Supplemental digital content is available in the text.
Objective Eighty percent of pancreatic ductal adenocarcinomas (PDAs) overexpress mucin 1 (MUC1), a transmembrane mucin glycoprotein. MUC1high PDA patients also express high levels of cycloox
Objective Eighty percent of pancreatic ductal adenocarcinomas (PDAs) overexpress mucin 1 (MUC1), a transmembrane mucin glycoprotein. MUC1high PDA patients also express high levels of cycloox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd6e87afbd4b384d49b08cc41174608
https://doi.org/10.1097/mpa.0000000000000371
https://doi.org/10.1097/mpa.0000000000000371
Genome-wide association study meta-analysis supports association between MUC1 and ectopic pregnancy.
Publikováno v:
Human Reproduction; Dec2023, Vol. 38 Issue 12, p2516-2525, 10p
Publikováno v:
Journal of Clinical & Diagnostic Research. Feb2021, Vol. 15 Issue 2, p8-13. 6p.
Autor:
Alikhani, Reza1 (AUTHOR), Taravati, Ali1 (AUTHOR), Hashemi-Soteh, Mohammad Bagher2 (AUTHOR) Hashemisoteh@gmail.com
Publikováno v:
BMC Medical Genetics. 7/13/2020, Vol. 21 Issue 1, p1-8. 8p.
Autor:
Guo, Ziheng1 (AUTHOR), Xia, Weiliang1,2 (AUTHOR) wlxia@sjtu.edu.cn
Publikováno v:
Med-X. 12/24/2024, Vol. 2 Issue 1, p1-49. 49p.